Efficacy of bisphosphonate as an adjunct to nonsurgical periodontal therapy in the management of periodontal disease: a systematic review

British Journal of Clinical Pharmacology

Volumn 83, Issue 3, 2017, Pages 444-454

  Akram, Zohaib ^a   Abduljabbar, Tariq ^b   Kellesarian, Sergio Varela ^c   Abu Hassan, Mohamed Ibrahim ^d   Javed, Fawad ^c   Vohra, Fahim ^b  

^a ZIAUDDIN UNIVERSITY   (Pakistan)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Bisphosphonates; periodontal disease; scaling and root planning; systematic review

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; NERIDRONIC ACID;

BONE DEFECT; CANNULA; DIABETES MELLITUS; DRUG EFFICACY; HUMAN; MENOPAUSE; META ANALYSIS; OBESITY; OUTCOME ASSESSMENT; PERIODONTAL ABSCESS; PERIODONTAL POCKET; PERIODONTITIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; ROOT PLANING; SCALING AND ROOT PLANING; SYRINGE; SYSTEMATIC REVIEW; CHRONIC PERIODONTITIS; DENTAL SCALING; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PROCEDURES; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ALENDRONATE; CHRONIC PERIODONTITIS; COMBINED MODALITY THERAPY; DENTAL SCALING; DIPHOSPHONATES; HUMANS; ROOT PLANING;

EID: 85000360797     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.13147     Document Type: Review

References (44)

1. Teles RP, Haffajee AD, Socransky SS. Microbiological goals of periodontal therapy. Periodontol 2000 2006; 42: 180–218.
2. Waerhaug J. Effect of rough surfaces upon gingival tissues. J Dent Res 1956; 35: 323–325.
3. Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 2002; 29: 22–32.
4. Vohra F, Akram Z, Safii SH, Vaithilingam RD, Ghanem A, Sergis K, et al. Role of antimicrobial photodynamic therapy in the treatment of aggressive periodontitis: a systematic review. Photodiagnosis Photodyn Ther 2015; 13: 139–147.
5. Akram Z, Al-Shareef SA, Daood U, Asiri FY, Shah AH, AlQahtani MA, et al. Bactericidal efficacy of photodynamic therapy against periodontal pathogens in periodontal disease: a systematic review. Photomed Laser Surg 2016; 34: 137–149.
6. Akram Z, Abduljabbar T, Sauro S, Daood U. Effect of photodynamic therapy and laser alone as adjunct to scaling and root planing on gingival crevicular fluid inflammatory proteins in periodontal disease: a systematic review. Photodiagnosis Photodyn Ther 2016. doi:10.1016/j.pdpdt.2016.09.004.
7. Abduljabbar T, Javed F, Shah A, Samer MS, Vohra F, Akram Z. Role of lasers as an adjunct to scaling and root planing in patients with type 2 diabetes mellitus: a systematic review. Lasers Med Sci 2016. doi:10.1007/s10103-016-2086-5.
8. Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000 2016; 71: 82–112.
9. Russell R, Watts N, Ebetino F, Rogers M. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008; 19: 733–759.
10. Giger EV, Castagner B, Leroux JC. Biomedical applications of bisphosphonates. J Control Release 2013; 167: 175–188.
11. Dunstan CR, Felsenberg D, Seibel MJ. Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 2007; 4: 42–55.
12. Reszka AA, Rodan GA. Mechanism of action of bisphosphonates. Curr Osteoporos Rep 2003; 1: 45–52.
13. Özdemir SP, Kurtis B, Tüter G, Bozkurt S, Gültekin SE, Sengüven B, et al. Effects of low-dose doxycycline and bisphosphonate clodronate on alveolar bone loss and gingival levels of matrix metalloproteinase-9 and interleukin-1β in rats with diabetes: a histomorphometric and immunohistochemical study. J Periodontol 2012; 83: 1172–1182.
14. Sapna G, Gokul S, Bagri-Manjrekar K. Matrix metalloproteinases and periodontal diseases. Oral Dis 2014; 20: 538–550.
15. Giannobile WV. Host-response therapeutics for periodontal diseases. J Periodontol 2008; 79: 1592–1600.
16. Pradeep A, Kumari M, Rao NS, Naik SB. 1% alendronate gel as local drug delivery in the treatment of class II furcation defects: a randomized controlled clinical trial. J Periodontol 2013; 84: 307–315.
17. Sharma A, Pradeep A. Clinical efficacy of 1% alendronate gel as a local drug delivery system in the treatment of chronic periodontitis: a randomized, controlled clinical trial. J Periodontol 2012; 83: 11–18.
18. Graziani F, Cei S, Guerrero A, La Ferla F, Vano M, Tonetti M, et al. Lack of short-term adjunctive effect of systemic neridronate in non-surgical periodontal therapy of advanced generalized chronic periodontitis: an open label-randomized clinical trial. J Clin Periodontol 2009; 36: 419–427.
19. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264–269.
20. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010; 63: e1–37.
21. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org (last accessed March 2016).
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
24. Sharma A, Pradeep A. Clinical efficacy of 1% alendronate gel in adjunct to mechanotherapy in the treatment of aggressive periodontitis: a randomized controlled clinical trial. J Periodontol 2012; 83: 19–26.
25. Pradeep A, Sharma A, Rao NS, Bajaj P, Naik SB, Kumari M. Local drug delivery of alendronate gel for the treatment of patients with chronic periodontitis with diabetes mellitus: a double-masked controlled clinical trial. J Periodontol 2012; 83: 1322–1328.
26. Lane N, Armitage GC, Loomer P, Hsieh S, Majumdar S, Wang HY, et al. Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study. J Periodontol 2005; 76: 1113–1122.
27. Rocha ML, Malacara JM, Sánchez-Marin FJ, de la Torre CJV, Fajardo ME. Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial. J Periodontol 2004; 75: 1579–1585.
28. Rocha M, Nava LE, de la Torre CV, Sánchez-Marín F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial. J Periodontol 2001; 72: 204–209.
29. Hughes D, MacDonald B, Russell R, Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Investig 1989; 83: 1930–1935.
30. Vitte C, Fleisch H, Guenther HL. Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinol 1996; 137: 2324–2333.
31. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567–1575.
32. Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition. J Am Dent Assoc 2005; 136: 1675–1681.
33. Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 2008; 13: 911–920.
34. Matesanz-Pérez P, García-Gargallo M, Figuero E, Bascones-Martínez A, Sanz M, Herrera D. A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol 2013; 40: 227–241.
35. Campanile VSM, Giannopoulou C, Campanile G, Cancela JA, Mombelli A. Single or repeated antimicrobial photodynamic therapy as adjunct to ultrasonic debridement in residual periodontal pockets: clinical, microbiological, and local biological effects. Lasers Med Sci 2015; 30: 27–34.
36. Koop R, Merheb J, Quirynen M. Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review. J Periodontol 2012; 83: 707–720.
37. Greenstein G. Local drug delivery in the treatment of periodontal diseases: assessing the clinical significance of the results. J Periodontol 2006; 77: 565–578.
38. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 1992; 63: 825–830.
39. Brennan M, Gleeson J, O'Brien F, McNamara L. Effects of ageing, prolonged estrogen deficiency and zoledronate on bone tissue mineral distribution. J Mech Behav Biomed Mater 2014; 29: 161–170.
40. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez F, Caudle R, Heft M. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 2005; 32: 40–44.
41. Zizzi A, Tirabassi G, Aspriello S, Piemontese M, Rubini C, Lucarini G. Gingival advanced glycation end-products in diabetes mellitus-associated chronic periodontitis: an immunohistochemical study. J Periodontal Res 2013; 48: 293–301.
42. Akram Z, Abduljabbar T, Abu-Hassan MI, Javed F, Vohra F. Cytokine profile in chronic periodontitis patients with and without obesity: a systematic review and meta-analysis. Dis Markers 2016. doi:10.1155/2016/4801418.
43. Akram Z, Safii SH, Vaithilingam RD, Baharuddin NA, Javed F, Vohra F. Efficacy of non-surgical periodontal therapy in the management of chronic periodontitis among obese and non-obese patients: a systematic review and meta-analysis. Clin Oral Investig 2016; 20: 903–914.
44. Akram Z, Rahim ZH, Taiyeb-Ali TB, Shahdan MS, Baharuddin NA, Vaithilingam RD, et al. Resistin as potential biomarker for chronic periodontitis: a systematic review and meta-analysis. Arch Oral Biol 2016. doi:10.1016/j.archoralbio.2016.08.016.